Haemonetics Corporation · NYSE:HAE

Johnson Lloyd Emerson received 2,538 Haemonetics Corporation shares as an award (Form 4)

Traded Jul 24, 2026 · Filed Jul 28, 2026

On Jul 24, 2026, Johnson Lloyd Emerson (Director) received 2,538 Haemonetics Corporation shares as an award, leaving 15,471 shares. Filed Jul 28, 2026 (Form 4).

Awarded
2,538 shares
Holding after
15,471 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 24, 2026Common StockAward2,53815,471Direct

Source

View original at SEC

Related